168 related articles for article (PubMed ID: 32319862)
1. LncRNA SNHG4 regulates miR-10a/PTEN to inhibit the proliferation of acute myeloid leukemia cells.
Yuan Z; Wang W
Hematology; 2020 Dec; 25(1):160-164. PubMed ID: 32319862
[No Abstract] [Full Text] [Related]
2. lncRNA TP73-AS1 Regulates miR-21/PTEN Axis to Affect Cell Proliferation in Acute Myeloid Leukemia.
Yuan Z; Li L; Zheng M; Xu J; Wang W
Cancer Biother Radiopharm; 2021 Apr; 36(3):268-272. PubMed ID: 32412786
[No Abstract] [Full Text] [Related]
3. CD4+ T cells from patients with acute myeloid leukemia inhibit the proliferation of bone marrow-derived mesenchymal stem cells by secretion of miR-10a.
Yu Z; Li D; Ju XL
J Cancer Res Clin Oncol; 2016 Apr; 142(4):733-40. PubMed ID: 26590574
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ANRIL promotes cell proliferation, migration and invasion during acute myeloid leukemia pathogenesis via negatively regulating miR-34a.
Wang CH; Li QY; Nie L; Ma J; Yao CJ; Chen FP
Int J Biochem Cell Biol; 2020 Feb; 119():105666. PubMed ID: 31830533
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma.
Xu R; Feng F; Yu X; Liu Z; Lao L
Cell Prolif; 2018 Dec; 51(6):e12515. PubMed ID: 30152090
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG4 regulates miR-138/c-Met axis to promote the proliferation of glioblastoma cells.
Wang X; Tian W; Wu L; Wei Z; Li W; Xu Y; Li Y
Neuroreport; 2020 Jun; 31(9):657-662. PubMed ID: 32427712
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA SNHG5 regulates chemotherapy resistance through the miR-32/DNAJB9 axis in acute myeloid leukemia.
Wang D; Zeng T; Lin Z; Yan L; Wang F; Tang L; Wang L; Tang D; Chen P; Yang M
Biomed Pharmacother; 2020 Mar; 123():109802. PubMed ID: 31884339
[TBL] [Abstract][Full Text] [Related]
8. MiR-718 mediates the indirect interaction between lncRNA SEMA3B-AS1 and PTEN to regulate the proliferation of hepatocellular carcinoma cells.
Zhong Y; Li Y; Song T; Zhang D
Physiol Genomics; 2019 Oct; 51(10):500-505. PubMed ID: 31251699
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-SNHG16 promotes proliferation and migration of acute myeloid leukemia cells via PTEN/PI3K/AKT axis through suppressing CELF2 protein.
Shi M; Yang R; Lin J; Wei QI; Chen L; Gong W; Li Y; Guo X
J Biosci; 2021; 46():. PubMed ID: 33576342
[TBL] [Abstract][Full Text] [Related]
10. High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937.
Wang Y; Zhou Q; Ma JJ
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):763-770. PubMed ID: 29461608
[TBL] [Abstract][Full Text] [Related]
11. HOTAIR suppresses PTEN via DNMT3b and confers drug resistance in acute myeloid leukemia.
Zhou W; Xu S; Chen X; Wang C
Hematology; 2021 Dec; 26(1):170-178. PubMed ID: 33538241
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG4 sponges miR-200b to inhibit cell apoptosis in diabetic retinopathy.
Yu J; Qin M; Li J; Cui S
Arch Physiol Biochem; 2023 Oct; 129(5):1117-1122. PubMed ID: 33822671
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG4 promotes neuroblastoma proliferation, migration, and invasion by sponging miR-377-3p.
Yang H; Guo JF; Zhang ML; Li AM
Neoplasma; 2020 Sep; 67(5):1054-1062. PubMed ID: 32614236
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MCM3AP-AS1 Regulates miR-21/PTEN Axis to Affect Cervical Squamous Cell Carcinoma Cell Proliferation and Apoptosis.
Yan G; Wan Z; Zhong Y; Chen M
Crit Rev Eukaryot Gene Expr; 2022; 32(4):49-56. PubMed ID: 35695665
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
[TBL] [Abstract][Full Text] [Related]
16. MiR-140 targets lncRNA FAM230B to suppress cell proliferation in acute myeloid leukemia running title: MiR-140 targets FAM230B in AML.
Wang Y; Wang F; Lu Y; Li Y; Ran H; Yan F; Tian Y
Hematology; 2022 Dec; 27(1):700-705. PubMed ID: 35666685
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155.
Yu Y; Kou D; Liu B; Huang Y; Li S; Qi Y; Guo Y; Huang T; Qi X; Jia L
Int J Lab Hematol; 2020 Aug; 42(4):464-472. PubMed ID: 32359033
[TBL] [Abstract][Full Text] [Related]
18. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG1 overexpression regulates the proliferation of acute myeloid leukemia cells through miR-488-5p/NUP205 axis.
Bao XL; Zhang L; Song WP
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5896-5903. PubMed ID: 31298340
[TBL] [Abstract][Full Text] [Related]
20. LncRNA GABPB1-IT1 inhibits the tumorigenesis of renal cancer via the miR-21/PTEN axis.
Tan C; Du H; Wang Y; Zhao J; Cheng X; Lan H
J Biochem Mol Toxicol; 2023 Apr; 37(4):e23288. PubMed ID: 36756790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
